Trump Escalates Trade War: US to Impose Sweeping 30% Tariffs on EU Goods Starting August 2025

Welcome to the European Union Tariff News and Tracker podcast. With significant changes shaking the landscape of transatlantic trade, today’s major headlines and analysis focus on tariffs between the US and the European Union, as well as the latest moves from President Trump’s administration. In a stunning escalation, US President Donald Trump announced in a letter to European Commission President Ursula von der Leyen that starting August 1, 2025, the US would impose a blanket 30 percent tariff on all EU products entering the United States, distinct from existing sectoral tariffs. This policy came with a warning: if the European Union responds with its own retaliatory tariffs, Trump pledged to add any EU increase on top of the existing US rate. This declaration has reverberated through European capitals and business communities, raising alarms in markets across sectors. Manufacturing faces intense pressure as the White House added 407 new items to its tariff list as recently as August. The new tariffs, including those on wind turbine components, railcars, and appliances, have shifted from raw materials to components—meaning even a single steel or aluminum part in a finished good can trigger a 50 percent surcharge at US borders. This marks the most aggressive US stance on EU imports since the first trade skirmishes began under Trump’s first term, with European industry groups urging Brussels to refocus its attention away from its dispute with China and toward this expanding American tariff regime. Sector-specific rates are adding complexity. For example, the White House recently clarified that for timber and lumber imports from the EU, Section 232 tariffs will not surpass 15 percent. Upholstered wooden furniture and kitchen cabinets face tariffs of 25 percent, rising to 30 and 50 percent respectively by January 2026. These rates have substantial implications for European exporters and US importers, particularly in manufacturing and construction supply chains. Pharmaceuticals have found some relief. A recent US-EU trade deal capped import tariffs on European pharmaceutical goods at 15 percent, a rate described by many analysts as manageable and considerably lower than the 20 percent or even 200 percent previously threatened by the Trump administration. The pact also implements Most Favored Nation pricing on generic drugs and chemical precursors—core ingredients in drug manufacturing—though questions persist on the full scope and enforcement of these measures. Legal uncertainty still hovers over much of this tariff regime. Trump’s use of the International Emergency Economic Powers Act to justify broad “reciprocal tariffs” is being tested at the Supreme Court, with trade and legal experts predicting up to an 80 percent chance the tariffs will be struck down before year-end. However, tariffs tied to national security authorities—applying, for example, to steel, aluminum, autos, and wood products—remain intact regardless of the court’s decision, a This content was created in partnership and with the help of Artificial Intelligence AI.